Healthcare Industry News: quality assurance
News Release - January 8, 2008
Candela Names Scott Blood Vice President of Quality Assurance and Regulatory Affairs
WAYLAND, Mass.--(HSMN NewsFeed)--Candela Corporation (NASDAQ: CLZR ) announced today that Scott Blood has joined the company as Vice President of quality assurance and Regulatory Affairs. In this newly created position, Mr. Blood will be responsible for driving best practices with respect to the company’s quality system and manufacturing processes and will serve as the primary liaison to regulatory agencies worldwide.“Scott’s extensive medical technology experience, specifically in the quality and regulatory disciplines, will support Candela’s continuing commitment to excellence. As we pursue additional products and applications beyond our core portfolio, we think Scott will enhance our ability to execute our strategy,” said Jay Caplan, Chief Operating Officer.
Mr. Blood has over 15 years of professional experience in the quality, regulatory, operations, and product design for life sciences companies. Most recently, he served as Vice President of Manufacturing and Quality at InfraReDx, Inc., a Burlington, Massachusetts-based medical device company. Mr. Blood is an Undergraduate Lecturer for Northeastern University for their Health Sciences degree program and currently serves as Chair of the New England Biomedical Discussion Group of the American Society of Quality.
Mr. Blood earned a Bachelors degree from Wentworth Institute of Technology. He is a Certified Quality Engineer, Certified Quality Auditor and also holds Regulatory Affairs Certification with the Regulatory Affairs Professionals Society.
ABOUT CANDELA: Candela Corporation manufactures, and distributes innovative clinical solutions that enable physicians, surgeons, and personal care practitioners to treat selected cosmetic and medical conditions using lasers, aesthetic laser systems, and other advanced technologies. Founded near Boston in 1970, the company markets and services its products in over 70 countries from offices and distributors in the United States, Europe, Japan, China and other Asian locations. Candela established the aesthetic laser market 18 years ago, and currently has an installed base of an estimated 12,000 lasers worldwide. Visit Candela on the Web at http://www.candelalaser.com.
Safe Harbor Statement: Except for the historical information contained herein, this news release contains forward-looking statements that constitute Candela's current intentions, hopes, beliefs, expectations or predictions of the future, which are therefore inherently subject to risks and uncertainties. Such statements may relate to, among other things, our future revenue, gross margin, expense levels and earnings, our growth prospects, market acceptance of our products, the strength of our distribution channels, our ability to add new products, our ability to expand regulatory approvals and the liquidity of our common stock. The risks and uncertainties that may affect forward-looking statements include, among others: the cancellation or deferral of customer orders, the risk of an adverse judgment in the patent litigation with Palomar Medical Technologies, Inc., dependence on a small number of strategic distribution relationships, difficulties in the timely development and market acceptance of new products, unanticipated increases in expenses, market developments that vary from the current public expectations concerning the growth of the laser industry, increased competitive pressures, changes in economic conditions, or difficulties in obtaining timely regulatory approvals. Further information on factors that could affect Candela's performance is included in Candela's periodic reports filed with the SEC. Candela cautions readers not to place undue reliance upon any such forward-looking statements, which speak only as of the date made. Candela expressly disclaims any obligations or undertaking to release publicly any updates or revisions to any such statements to reflect any change in Candela's expectations or any change in events, conditions or circumstances on which any such statement is based.
Source: Candela
Issuer of this News Release is solely responsible for its
content.
Please address inquiries directly to the issuing company.
FindReps: Screen and connect with Medical Sales Rep candidates (Direct Reps and Independents) – anonymously, in real time.
RepJobs: Job Opportunities for Direct Sales Reps and New Product Lines for Independents!